Clinical trial
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
NCT00227240 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00227240 |
|---|---|
| Title | Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis |
| Official title | Observational Study With Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Plaque Psoriasis |
| Enrollment | 753 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 27, 2005 |
| Last update posted | Mar 21, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: